Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$4.29 - $5.97 $110,184 - $153,333
-25,684 Reduced 10.37%
221,913 $1.01 Million
Q4 2023

Oct 21, 2024

SELL
$3.91 - $5.93 $105,198 - $159,546
-26,905 Reduced 9.8%
247,597 $1.41 Million
Q4 2023

Feb 07, 2024

SELL
$3.91 - $5.93 $105,198 - $159,546
-26,905 Reduced 9.8%
247,597 $1.41 Million
Q3 2023

Oct 21, 2024

SELL
$4.6 - $7.95 $492,770 - $851,635
-107,124 Reduced 28.07%
274,502 $1.26 Million
Q3 2023

Nov 07, 2023

SELL
$4.6 - $7.95 $492,770 - $851,635
-107,124 Reduced 28.07%
274,502 $1.26 Million
Q2 2023

Oct 21, 2024

BUY
$5.66 - $7.59 $1.64 Million - $2.2 Million
289,626 Added 314.81%
381,626 $2.47 Million
Q2 2023

Aug 07, 2023

BUY
$5.66 - $7.59 $1.64 Million - $2.2 Million
289,626 Added 314.81%
381,626 $2.47 Million
Q1 2023

Oct 21, 2024

BUY
$7.31 - $11.18 $672,520 - $1.03 Million
92,000 New
92,000 $693,000
Q1 2023

May 03, 2023

BUY
$7.31 - $11.18 $672,520 - $1.03 Million
92,000 New
92,000 $693,000
Q3 2022

Nov 07, 2022

SELL
$9.2 - $13.68 $388,350 - $577,460
-42,212 Reduced 15.48%
230,400 $2.28 Million
Q2 2022

Aug 09, 2022

BUY
$5.72 - $10.65 $135,632 - $252,532
23,712 Added 9.53%
272,612 $2.9 Million
Q1 2022

May 12, 2022

BUY
$7.46 - $14.14 $1.45 Million - $2.75 Million
194,800 Added 360.07%
248,900 $2.43 Million
Q4 2021

Feb 10, 2022

BUY
$12.99 - $17.73 $176,053 - $240,294
13,553 Added 33.43%
54,100 $774,000
Q3 2021

Nov 12, 2021

SELL
$14.85 - $21.34 $1.13 Million - $1.63 Million
-76,253 Reduced 65.29%
40,547 $813,000
Q2 2021

Aug 13, 2021

BUY
$20.19 - $34.17 $2.36 Million - $3.99 Million
116,800 New
116,800 $2.57 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.